13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 67 holding rows worth $374,832,080.
- Accession
- 0001420506-24-000248
- Filer
- CIK 1952142
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 70 entries on the cover page, a total value of $374,832,080 stated on the cover page (in dollars after the unit check, H1), rows summing to $374,832,080 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,169,116 | $24,359,173 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,094,494 | $23,652,015 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 313,604 | $17,405,022 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 501,806 | $13,799,665 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 322,015 | $13,566,492 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 862,815 | $12,243,345 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 513,681 | $11,778,705 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,020,214 | $10,742,853 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 253,948 | $10,251,881 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 450,706 | $10,231,026 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 167,851 | $10,136,522 | dollars as filed | |
| ARGENX SE | 04016X901 | CALL | 26,484 | $10,075,308 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 89,016 | $9,704,524 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 61,011 | $9,562,864 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 249,575 | $8,879,879 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 15,067 | $8,782,856 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,790,182 | $8,763,558 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 2,594,536 | $8,380,351 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 378,766 | $8,151,044 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD | 881624909 | CALL | 701,597 | $7,324,673 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 125,429 | $7,244,779 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 108,911 | $6,752,482 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 104,650 | $6,296,791 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 856,952 | $6,162,295 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 173,579 | $5,379,213 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 423,174 | $5,183,882 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 111,354 | $4,765,951 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 218,319 | $4,730,973 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 20,444 | $4,730,333 | dollars as filed | |
| SPY | 78462F103 | SHS | 9,921 | $4,715,551 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 85,382 | $4,707,963 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 246,178 | $4,692,153 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 408,257 | $4,560,231 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 587,373 | $4,381,803 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 182,258 | $4,304,934 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 281,287 | $3,946,457 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 783,172 | $3,563,433 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 567,211 | $3,556,413 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 898,196 | $3,359,253 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 183,102 | $3,211,609 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 907,152 | $3,038,959 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 22,500 | $2,964,600 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871903 | CALL | 3,707,110 | $2,924,910 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 451,375 | $2,906,855 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 607,100 | $2,756,234 | dollars as filed | |
| MORPHOSYS AG | 617760902 | CALL | 277,485 | $2,747,102 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 376,573 | $2,541,868 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 95,732 | $2,212,367 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 434,588 | $2,172,940 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 24,111 | $2,013,027 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 59,038 | $1,806,563 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 126,101 | $1,795,678 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 58,450 | $1,452,483 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 279,648 | $1,247,230 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 83,381 | $1,227,368 | dollars as filed | |
| SPY | 78462F103 | SHS | 6,500 | $1,188,500 | dollars as filed | put |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 147,752 | $1,053,472 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 45,000 | $963,900 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 30,990 | $627,548 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 26,875 | $622,156 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 1,500 | $573,750 | dollars as filed | put |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 5,000 | $375,000 | dollars as filed | put |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,000 | $371,250 | dollars as filed | call |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 2,000 | $360,000 | dollars as filed | put |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 500 | $335,000 | dollars as filed | put |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 623 | $283,465 | dollars as filed | call |
| INVESCO QQQ TR | 46090E103 | COM | 600 | $231,600 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000248 | this filing | 2024-02-13 | acceptance time not in the bulk data set |